1. Liu, Mengyuan, Zhao, Qiurong, Zheng, Xiang, Li, Xueying, Wu, Mingsong. 2022. Transcriptome changes in ERGIC3-knockdown hepatocellular carcinoma cells: ERGIC3 is a novel immune function related gene. In PeerJ, 10, e13369. doi:10.7717/peerj.13369. https://pubmed.ncbi.nlm.nih.gov/35602902/
2. Wu, Mingsong, Tu, Tao, Huang, Yunchao, Cao, Yi. 2013. Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene. In BMC cancer, 13, 44. doi:10.1186/1471-2407-13-44. https://pubmed.ncbi.nlm.nih.gov/23374247/
3. Lin, Qing-Hai, Zhang, Kui-Dong, Duan, He-Xian, Wei, Wan-Li, Cao, Yi. 2015. ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer. In Cancer science, 106, 1463-73. doi:10.1111/cas.12741. https://pubmed.ncbi.nlm.nih.gov/26177443/
4. Järvelä, Irma, Määttä, Tuomo, Acharya, Anushree, Leal, Suzanne M, Schrauwen, Isabelle. 2021. Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland. In Human genetics, 140, 1011-1029. doi:10.1007/s00439-021-02268-1. https://pubmed.ncbi.nlm.nih.gov/33710394/